National projects
Range:
Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity
Cancer remains an important cause of mortality and economic losses worldwide. The Bilateral Project provides excellent research in new anticancer discovery for the treatment of gastrointestinal (GI) carcinomas (colorectal, gastric, liver and pancreatic cancers), where hEag1 potassium channels are overexpressed in 75 to 100% cases. GI carcinomas are among the 10 most...
01. January 2019 - 31. December 2022 | 1-09 Natural sciences and Mathematics - Pharmacy
Development of new carbamate-based imaging probes for cholinesterases
Cholinesterases (ChEs) are polymorphic serine hydrolases that catalyse the hydrolysis of neurotransmitter acetylcholine (ACh) and other esters. Two ChEs are found in vertebrates: acetylcholinesterase (AChE) and butyrycholinesterase (BChE). Both enzymes are involved not only in physiological processes but also in several pathophysiological processes (e.g. Alzhe...
01. July 2018 - 31. March 2021 | 1-09 Natural sciences and Mathematics - Pharmacy
Development of novel Hsp90 inhibitors with anticancer activity
Scientific background and problem identification. Despite considerable improvements in treatment and survival times, cancer still remains one of the leading causes of mortality worldwide. Therefore, there is an urgent need to identify new drugs acting on new targets to improve treatment outcomes, especially against some aggressive types with no standard therapies, s...
01. January 2019 - 30. June 2023 | 1-09 Natural sciences and Mathematics - Pharmacy
Targeted covalent inhibitors: inhibiting monoamine oxidase through non-catalytic amino-acid residues
Monoamine oxidase (MAO) is a flavin-dependent enzyme that catalyzes the oxidation of amines, and has an important role in the homeostasis of biogenic and exogenic amines. Two isoforms of MAO (i.e., MAO-A and MAO-B) are present in most mammalian tissues and are distinguished by their sensitivities to acetylenic inhibitors clorgyline and L-deprenyl, and by their subst...
01. July 2019 - 30. June 2021 | 1-09 Natural sciences and Mathematics - Pharmacy
Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods
The proteasome is an intracellular protease that represents a vital part of the ubiquitin-proteasome system. It degrades a wide range of proteins and has critical functions in many biological processes including cell cycle control, apoptosis, inflammation, and signal transduction. The constitutive isoform (cCP) of the proteasome is expressed in all eukaryotic cells ...
01. November 2017 - 31. October 2020 | 1-09 Natural sciences and Mathematics - Pharmacy
Nanomedicines with antibiotics and probiotics for local treatment of periodontal disease
Periodontal disease is perhaps the most common human afflictions, and through its local and systemic effects, it can considerably deteriorate the overall quality of person’s life. Periodontal disease is a biofilm-induced chronic inflammation of the periodontium, where two factors are specifically linked with its pathogenesis: (i) a shift in the oral microbiota...
01. July 2018 - 30. June 2022 | 1-09 Natural sciences and Mathematics - Pharmacy
Butyrylcholinesterase inhibitors for alleviating symptoms of Alzheimer's disease
Memory and cognitive deficits of patients with AD are the result of severely decreased brain levels of ACh. Currently approved ChEs inhibitors in AD therapy (donepezil, galantamine and rivastigmine) alleviate symptoms of the disease by increasing brain levels of ACh. They achieve this by preventing the breakdown of ACh through inhibition of the enzymes that hydrolyz...
01. July 2018 - 30. June 2020 | 1-09 Natural sciences and Mathematics - Pharmacy
Discovery of new inhibitors of bacterial peptidoglycan biosynthesis enzymes MurA and MurB
Nowadays, we are in a transition era where it is evident that therapy of bacterial infections is not a trivial task, understood by modern medicine and supplied with abundant medicines. Emergence of bacterial resistance, globalisation and access to modern medicinal practice together with a decreasing output of antibacterial discovery pipeline, projects a major concer...
01. May 2017 - 30. April 2019 | 1-09 Natural sciences and Mathematics - Pharmacy
Development of multifunctional compounds for treatment of Alzheimer's disease
The ageing of the population has resulted in an increase in the number of people with age-related diseases such as dementia. With more than 35 million people affected worldwide, Alzheimer’s disease (AD) is the most prominent form of senile dementia. The number of patients afflicted with this progressive neurodegenerative disorder will continue to grow and is e...
30. April 2017 - 30. April 2020 | 1-09 Natural sciences and Mathematics - Pharmacy